https://doi.org/10.1038/nature12903
F
Fugen Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
161
Papers
4.2K
Citations
28
h-index
47
i10-index
Fugen Li is an academic researcher from Nanchang University. The author has contributed to research in topics: Cancer Genomics and Diagnostics & Lung Cancer Treatments and Mutations & RNA modifications and cancer. The author has an h-index of 28, co-authored 137 publications.
ORCID: 0000-0002-1491-7667Papers by this author
worksBroadly permissive intestinal chromatin underlies lateral inhibition and cell plasticity
2014 · Nature · 263 citations
ChiLin: a comprehensive ChIP-seq and DNase-seq quality control and analysis pipeline
2016 · BMC Bioinformatics · 135 citations
https://doi.org/10.1186/s12859-016-1274-4
The characteristics of ctDNA reveal the high complexity in matching the corresponding tumor tissues
2018 · BMC Cancer · 75 citations
https://doi.org/10.1186/s12885-018-4199-7
Atlas of prostate cancer heritability in European and African-American men pinpoints tissue-specific regulation
2016 · Nature Communications · 58 citations
https://doi.org/10.1038/ncomms10979
Gumarontinib in patients with non-small-cell lung cancer harbouring MET exon 14 skipping mutations: a multicentre, single-arm, open-label, phase 1b/2 trial
2023 · EClinicalMedicine · 48 citations
https://doi.org/10.1016/j.eclinm.2023.101952
Identification of predictors of drug sensitivity using patient-derived models of esophageal squamous cell carcinoma
2019 · Nature Communications · 38 citations
https://doi.org/10.1038/s41467-019-12846-7
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat